Leading pharma companies are turning to big data, machine learning and analytics to reduce the time and cost of clinical trials and to bring new drugs to market faster. But many companies feel frustrated by their efforts to deploy data and analytics, according to a recent Bain & Company survey. New solutions require companies to modernize data pipelines and data architecture.
Christoph Schlegel and Reynold Strossen are partners with Bain & Company’s Healthcare practice. Christoph is based in the firm’s Frankfurt office; Reynold is located in the New York office.